Panacea Life Sciences Holdings, Inc.
PLSH
Rank in Stocks
#32575
Panacea Life Sciences Holdings, Inc. operates as an integrated research and... Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products across the entire supply chain, from sourcing to final sale. Its core mission is to develop and deliver natural, pharmaceutical-grade alternatives for both human and pet consumption. The company's diverse product range encompasses items such as softgels, edible gummies, liquid tinctures, sublingual tablets, and a variety of cosmetic and topical applications. In addition to these offerings, the company is involved in the personal protective equipment (PPE) market, importing and distributing hand sanitizers and masks. Panacea Life Sciences also provides white-label and contract manufacturing services to other cannabinoid companies, sells raw materials, and manages tolling arrangements. Established in 2008, the company is headquartered in Greenwood Village, Colorado.
Share Price
$0.0828
Last synced: 2026-11-10
Market Cap
$4.92M
Change (1 day)
22.34%
Change (1 year)
38.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Panacea Life Sciences Holdings, Inc. (PLSH)
Category
Healthcare
EPS for Panacea Life Sciences Holdings, Inc. (PLSH)
EPS as of June 2026 TTM: $-0.10
According to Panacea Life Sciences Holdings, Inc.'s latest financial reports, its current EPS (TTM) is $-0.10. At the end of 2025 the company had an EPS of $-0.01, an increase over its 2024 EPS of $-0.03.
EPS history for Panacea Life Sciences Holdings, Inc. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.10 | 900.00% |
| 2025 | $-0.01 | -77.85% |
| 2024 | $-0.03 | -93.42% |
| 2023 | $-0.48 | -36.00% |
| 2022 | $-0.75 | 120.59% |
| 2021 | $-0.34 | -17.07% |
| 2020 | $-0.41 | -94.76% |
| 2019 | $-7.83 | -69.28% |
| 2018 | $-25.49 | 10,982.61% |
| 2017 | $-0.23 | -98.77% |
| 2016 | $-18.68 | -88.07% |
| 2015 | $-156.61 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -6,601.40% |
DE
|
|
| $6.08 | -6,177.60% |
DE
|
|
| $1.55 | -1,650.60% |
JP
|
|
| $3.66 | -3,760.00% |
CH
|
|
| $0.45 | -550.00% |
IL
|
Questions about Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS)
What is Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS)?
Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS) over the last twelve months is $-0.10, as of Jun 2026.
What was Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS) in 2025?
In 2025, Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS) was $-0.01, compared with $-0.03 in 2024.
How has Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2022 ($-0.75).
How does Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS) compare with similar companies?
Panacea Life Sciences Holdings, Inc.'s earnings per share (EPS) ($-0.10) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.